Adria Trapani-Barnacz
Psychiatric/Mental Health · Princeton, NJNPI 1831310309
Payments from drug & device makers
Across 162 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$793
- Lundbeck LLC$487
- Axsome Therapeutics, Inc.$352
- Otsuka America Pharmaceutical, Inc.$339
- AbbVie$310
- Tris Pharma Inc$180
- plus $550 from 12 others
Across 6 payments — averaging $203.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
What the payments were for
- Food & beverage$3,000100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,012 in reported general payments places this provider in the 85th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 17 | $38,085 |
| Methylphenidate ErMethylphenidate Hcl | 12 | $1,841 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 32 | $1,666 |
| Duloxetine Hcl | 35 | $1,039 |
| Bupropion XlBupropion Hcl | 29 | $982 |
| Lamotrigine | 63 | $700 |
| Levothyroxine Sodium | 14 | $474 |
| Guanfacine Hcl ErGuanfacine Hcl | 11 | $400 |
| Mirtazapine | 17 | $370 |
| Buspirone Hcl | 13 | $305 |
| Trazodone Hcl | 15 | $285 |
| Clonazepam | 68 | $285 |
| Olanzapine | 12 | $255 |
| Escitalopram Oxalate | 31 | $229 |
| Lorazepam | 37 | $193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $793 | $38,08517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Other psychiatric/mental health in Princeton
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
- Marisa SavicOradel$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.